$1.18
-0.02 (-1.26%)
Open$1.19
Previous Close$1.19
Day High$1.21
Day Low$1.10
52W High$1.72
52W Low$0.23
Volume—
Avg Volume41.9K
Market Cap52.30M
P/E Ratio—
EPS$-0.17
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 44.46M | 45.50M | 43.44M |
| Net Income | 5.47M | 5.03M | 5.89M |
| Profit Margin | 12.3% | 11.1% | 13.6% |
| EBITDA | 8.24M | 9.46M | 8.95M |
| Free Cash Flow | 4.73M | 3.67M | 4.46M |
| Rev Growth | +4.4% | +9.5% | -0.1% |
| Debt/Equity | 0.49 | 0.48 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |